Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Athletics-Salazar's four-year ban upheld by CAS

Published 09/15/2021, 04:59 PM
Updated 09/16/2021, 10:32 AM
© Reuters. FILE PHOTO: Coach Alberto Salazar stands in front of Galen Rupp of the U.S.A. in the Bird's Nest Stadium at the Wold Athletics Championships in Beijing, China, August 21, 2015. REUTERS/Phil Noble

(Reuters) -American Alberto Salazar, who has coached some of the world's top long-distance runners, had his four-year suspension for a series of anti-doping rule violations upheld by the highest court in sport.

The 63-year-old, who guided Britain's Mo Farah to Olympic titles, was banned by the U.S. Anti-Doping Agency (USADA) in 2019 for "orchestrating and facilitating" doping as head coach of the Nike (NYSE:NKE) Oregon Project, an elite camp designed primarily to develop U.S. endurance athletes.

The Court of Arbitration for Sport (CAS) said in a statement on Thursday it had upheld the ban on Salazar as well as that on endocrinologist Jeffrey Brown, who worked alongside him.

"CAS confirms the four-year bans imposed on Dr. Jeffrey Brown and Alberto Salazar for anti-doping rule violations," the court said https://www.tas-cas.org/fileadmin/user_upload/CAS_Media_Release_6530.pdf.

Salazar was found guilty of possessing testosterone, complicity in Brown's administration of a prohibited method, and tampering with the doping control process, CAS said.

Brown was found guilty of complicity in Salazar's possession of testosterone, trafficking testosterone to Salazar, administration of a prohibited method, and tampering with the doping control process.

However, the court rejected USADA's appeal to increase the bans on Salazar and Brown beyond four years and criticised its handling of the case, calling it "out of proportion and excessive".

"The relief requested by Dr. Brown/Mr. Salazar, on one hand, and by USADA, on the other hand, in their respective appeals has been rejected," CAS said.

"None of the ADRVs (anti-doping rule violations) directly affected athletic competition, and ... there was no evidence put before the CAS as to any effect on athletes competing at the elite level."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

USADA said in a statement it was "pleased" the CAS panel had upheld Salazar and Brown's suspensions.

"Hopefully, this sends a powerful message that when athletes come to us with information of doping violations or other misconduct, they know we will listen to them and protect them by pursuing the evidence, no matter the power, influence or financial resources of those in violation -- even those, like here, who orchestrate cover-ups and attempt to obstruct the truth," USADA said.

"While this CAS case dealt only with technical anti-doping rule violations, the whistleblowers who came forward prompted an ensuing investigation that resulted in a cascading effect, exposing a toxic and unhealthy culture at the Nike Oregon Project, and unacceptable behaviours and practices against athletes that were carried out by people at the top of the programme sworn to protect them."

USADA investigated Salazar for four years and concluded that he had trafficked testosterone to multiple athletes. The agency also said he tampered or attempted to tamper with Nike Oregon Project athletes' doping control process.

Salazar won three consecutive New York City Marathons from 1980 before coaching a number of Olympians, including Farah, who won gold medals in the 5,000 and 10,000 metres at the 2012 London and 2016 Rio Games.

Farah has never failed a drugs test and has not been accused of any wrongdoing. Salazar stopped coaching Farah in 2017, when the runner decided to move back to England. Farah said at the time that the doping investigation was not the reason they parted ways.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.